Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage-Reference-Cited by-同舟云学术

Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage

Published:2019-12-06 Issue:12 Volume:2 Page:e1917053
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Tatangelo Mark¹²,Tomlinson George¹²,Paterson J. Michael¹³,Ahluwalia Vandana⁴,Kopp Alex³,Gomes Tara¹³⁵,Bansback Nick⁶,Bombardier Claire¹²

Affiliation:

1. University of Toronto, Toronto, Ontario, Canada

2. University Health Network, Toronto, Ontario, Canada

3. ICES, Toronto, Ontario, Canada

4. William Osler Health Care Centre, Brampton, Ontario, Canada

5. St Michael’s Hospital, Toronto, Ontario, Canada

6. University of British Columbia, Vancouver, British Columbia, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2757256/tatangelo_2019_oi_190645.pdf

Reference43 articles.

1. Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists.;Widdifield;Arthritis Care Res (Hoboken),2013

2. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.;Bykerk;J Rheumatol,2012

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.;Smolen;Ann Rheum Dis,2017

4. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis.;Singh;Arthritis Care Res (Hoboken),2016

5. Canadian variation by province in rheumatoid arthritis initiating anti-tumor necrosis factor therapy: results from the optimization of adalimumab trial.;Pease;J Rheumatol,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of socioeconomic status on biologics utilization in rheumatoid arthritis: revealing inequalities and healthcare efficiency;The Korean Journal of Internal Medicine;2024-07-01

2. Sex Differences in Time to Initiate Nonsteroidal Anti‐Inflammatory Drugs or Biologic Disease‐Modifying Antirheumatic Drugs Among Patients With Axial Spondyloarthritis;Arthritis Care & Research;2024-05-16

3. Development of a Machine Learning Model to Predict the Use of Surgery in Rheumatoid Arthritis Patients;Arthritis Care & Research;2023-12-28

4. Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis;JAMA Network Open;2023-10-06

5. Phenolic-Compound-Rich Opuntia littoralis Ethyl Acetate Extract Relaxes Arthritic Symptoms in Collagen-Induced Mice Model via Bone Morphogenic Markers;Nutrients;2022-12-17